FDA states substantial evidence of efficacy was not demonstrated.

The initiative aims to identify and support new ideas for innovative oral formulations for peptide drugs such as GLP-1 ...

IQVIA and Veeva Systems announced global clinical and commercial partnerships and the complete resolution of all pending ...

Systlmmune and BMS’ ACD treats patients with previously treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer.

In partnership with the University of Oxford’s Pandemic Sciences Institute, the grant will advance oral vaccine delivery.

Developed by Daiichi Sankyo and Merck, it treats patients with Pretreated Extensive-Stage Small Cell Lung Cancer.

Precigen, Inc., a biopharmaceutical company specializing in the advancement of innovative precision medicines to improve the ...

AbbVie will invest $195 million in its North Chicago, Illinois, manufacturing plant to expand domestic API production in the ...

Anocca AB ( Anocca ), a clinical-stage T-cell immunotherapy company, raised SEK ~440 million (USD ~46 million) in financing. Mellby Gård led the financing with strong support from AMF, Ramsbury, and ...

Bayer and Kumquat Biosciences have entered an exclusive global license and collaboration to develop and commercialize Kumquat ...

ProBio has launched cGMP Adeno-Associated Virus (AAV) manufacturing services at its 128,000 sq. ft. facility in Hopewell, New ...

Sartorius supports commercialization and joint development of solutions based on Nanotein’s NanoSpark platform.